Capecitabine and streptozocin +/- cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial.
Authors
Meyer, TQian, W
Valle, Juan W
Talbot, D
Cunningham, D
Reed, N
Meyer, T
Wall, L
Waters, J
Ross, P
Anthoney, A
Sumpter, K
Sarwar, N
Crosby, T
Begum, N
Young, G
Hardy, R
Corrie, P
Affiliation
Department of Oncology, Royal Free London NHS Foundation Trust, London,Issue Date
2016